Riskpilot← Back to searchSign inGet full accessBlastoCare AB
ABActiveOrg 5591109847Tulegatan 45Diagnostic imaging services and medical laboratory activities · NACE 8691Est. 20170 employees
Revenue 2025
SEK 0
EBITDA margin
—
-33% vs 2024
Equity ratio
99.7%
Financial strength
Net profit 2025
SEK -28K
-112% vs 2024
| Revenue | SEK 0 | — |
| EBITDA | SEK -28K | -33% |
| Net profit | SEK -28K | -112% |
| Total assets | SEK 1,5M | -2% |
| Equity | SEK 1,5M | -2% |
| Employees | 0 | — |
Legal name
BlastoCare AB
Org number
5591109847
Legal form
Aktiebolag
NACE code
8691 · Diagnostic imaging services and medical laboratory activities
Founded
4 maj 2017
Share capital
SEK 50 000
Employees
0
VAT registered
No
Audit selected
No
Last report
2025-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen
Company purpose
Aktiebolaget ska bedriva hälso-, frisk- och sjukvårdsverksamhet, forskning och föreläsningar. Framtagande av utbildning- och undervisningsmaterial, utbildning, utveckling och rådgivningsverksamhet inom reproduktionsmedicin, embrylogi, uppbygnad och drift av laboratorium för vävnadsinrättning och kvalitetskontroll av reproduktionmedicinsk verksamhet. Entreprenörskap i uppstart av verksamhet relaterad till reproduktionsmedicin, embrylogi och vävnadsinrättning bemanning, personaluthyrning. Bedriva handel med medicinsk och laboratorieutrustningar, författarverksamhet och företagshälsovård. Äga och förvalta fast och lös egendom, fastighetsförvaltning, värdepappershandel samt därmed förenlig verksamhet.
Address
Tulegatan 45
Email
mona.m.sheikhi@gmail.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 0 | 53 | 0 | 0 | 0 |
| Staff expenses | — | −4 | −6 | −5 | −5 |
| EBITDA | −2 | 37 | −13 | −21 | −28 |
| Depreciation & amort. | −0 | — | — | — | — |
| EBIT | −2 | 37 | −13 | −21 | −28 |
| Net financials | −206 | 550 | 551 | 257 | 0 |
| Profit before tax | 203 | 587 | 537 | 236 | −28 |
| Tax | −0 | −4 | — | — | — |
| Net profit | 203 | 582 | 537 | 236 | −28 |
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Total assets | 349 | 765 | 1 308 | 1 499 | 1 474 |
| Equity | 234 | 726 | 1 263 | 1 499 | 1 471 |
| Long-term debt | 0 | — | — | — | — |
| Short-term debt | 116 | 39 | 45 | 0 | 4 |
| Total debt | 116 | 39 | 45 | 0 | 4 |
EBITDA margin
-2822500.0%
This company
15.8%
Market median
-17864024% vs market
20212025
Equity ratio
99.7%
This company
38.2%
Market median
+161% vs market
20212025
Return on equity
-1.9%
This company
18.4%
Market median
-110% vs market
20212025
Net profit margin
-2820200.0%
This company
8.1%
Market median
-34817384% vs market
20212025
Asset turnover
0.00×
This company
1.12×
Market median
-100% vs market
20212025
Debt / equity
0.00×
This company
0.62×
Market median
+100% vs market
20212025
- Annual report 2025Filed via Bolagsverket / SCB · Period 2025-01-01 – 2025-12-31
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
No data on file.
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
| Deputy Board Member | 2022 | |
| Board of Directors | 2022 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of BlastoCare AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Sara Delorén | Deputy Board Member | 0 companies |
| Mona Sheikhi | Board of Directors | 0 companies |